AllianceBernstein’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.32M | Buy |
102,643
+471
| +0.5% | +$17.4K | ﹤0.01% | 1605 |
|
|
2025
Q4 | $4.3M | Buy |
102,172
+8,332
| +9% | +$336K | ﹤0.01% | 1616 |
|
|
2025
Q3 | $3.22M | Sell |
93,840
-347
| -0.4% | -$9.96K | ﹤0.01% | 1736 |
|
|
2025
Q2 | $2.55M | Buy |
94,187
+2,167
| +2% | +$62.8K | ﹤0.01% | 1808 |
|
|
2025
Q1 | $2.73M | Sell |
92,020
-6,400
| -7% | -$244K | ﹤0.01% | 1737 |
|
|
2024
Q4 | $3.9M | Buy |
98,420
+2,000
| +2% | +$75.7K | ﹤0.01% | 1608 |
|
|
2024
Q3 | $3.28M | Sell |
96,420
-3,000
| -3% | -$84.4K | ﹤0.01% | 1715 |
|
|
2024
Q2 | $2.15M | Hold |
99,420
| – | – | ﹤0.01% | 1912 |
|
|
2024
Q1 | $2.2M | Sell |
99,420
-1,970
| -2% | -$48.1K | ﹤0.01% | 1869 |
|
|
2023
Q4 | $2.79M | Buy |
101,390
+2,300
| +2% | +$55.5K | ﹤0.01% | 1761 |
|
|
2023
Q3 | $2.21M | Sell |
99,090
-1,241
| -1% | -$31.9K | ﹤0.01% | 1823 |
|
|
2023
Q2 | $2.56M | Buy |
100,331
+22,431
| +29% | +$544K | ﹤0.01% | 1766 |
|
|
2023
Q1 | $1.74M | Hold |
77,900
| – | – | ﹤0.01% | 1945 |
|
|
2022
Q4 | $1.85M | Hold |
77,900
| – | – | ﹤0.01% | 1962 |
|
|
2022
Q3 | $1.29M | Hold |
77,900
| – | – | ﹤0.01% | 2152 |
|
|
2022
Q2 | $1.55M | Hold |
77,900
| – | – | ﹤0.01% | 2102 |
|
|
2022
Q1 | $2.15M | Sell |
77,900
-35,120
| -31% | -$1M | ﹤0.01% | 2049 |
|
|
2021
Q4 | $4.66M | Buy |
113,020
+34,630
| +44% | +$1.53M | ﹤0.01% | 1658 |
|
|
2021
Q3 | $3.64M | Buy |
78,390
+90
| +0.1% | +$3.93K | ﹤0.01% | 1779 |
|
|
2021
Q2 | $3.13M | Hold |
78,300
| – | – | ﹤0.01% | 1910 |
|
|
2021
Q1 | $4.21M | Buy |
78,300
+700
| +0.9% | +$40.3K | ﹤0.01% | 1664 |
|
|
2020
Q4 | $3.8M | Buy |
77,600
+600
| +0.8% | +$27.8K | ﹤0.01% | 1647 |
|
|
2020
Q3 | $2.5M | Buy |
77,000
+13,200
| +21% | +$420K | ﹤0.01% | 1724 |
|
|
2020
Q2 | $1.65M | Hold |
63,800
| – | – | ﹤0.01% | 1949 |
|
|
2020
Q1 | $1.55M | Sell |
63,800
-1,000
| -2% | -$25.2K | ﹤0.01% | 1821 |
|
|
2019
Q4 | $1.81M | Buy |
64,800
+1,000
| +2% | +$25.9K | ﹤0.01% | 2017 |
|
|
2019
Q3 | $1.53M | Buy |
63,800
+1,500
| +2% | +$39.9K | ﹤0.01% | 2067 |
|
|
2019
Q2 | $1.78M | Buy |
62,300
+31,900
| +105% | +$797K | ﹤0.01% | 2039 |
|
|
2019
Q1 | $761K | Buy |
30,400
+2,000
| +7% | +$38.2K | ﹤0.01% | 2368 |
|
|
2018
Q4 | $357K | Buy |
28,400
+15,100
| +114% | +$179K | ﹤0.01% | 2636 |
|
|
2018
Q3 | $127K | Buy |
13,300
+2,700
| +25% | +$29.8K | ﹤0.01% | 3060 |
|
|
2018
Q2 | $99K | Buy |
+10,600
| New | +$74.5K | ﹤0.01% | 3054 |
|
|
2015
Q2 | – | Sell |
-500
| Closed | -$4K | – | 3263 |
|
|
2015
Q1 | $4K | Hold |
500
| – | – | ﹤0.01% | 3441 |
|
|
2014
Q4 | $5K | Hold |
500
| – | – | ﹤0.01% | 3375 |
|
|
2014
Q3 | $5K | Sell |
500
-500
| -50% | -$6.56K | ﹤0.01% | 3355 |
|
|
2014
Q2 | $17K | Buy |
+1,000
| New | +$14.4K | ﹤0.01% | 3255 |
|
Other funds holding VCYT
VPM
VCM
AIM
AllianceBernstein's VCYT Position: Q1 2026 in Review
AllianceBernstein increased its Veracyte (VCYT) stake by 0.46% in Q1 2026, buying an estimated $17.4K and bringing the position to 102,643 shares worth $4.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1605.
AllianceBernstein first reported a position in VCYT in Q2 2014 and has held it in 36 quarters since. The position peaked at $4.66M in Q4 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- AllianceBernstein held 102,643 shares of Veracyte worth $4.32M as of Q1 2026.
- AllianceBernstein bought 471 Veracyte shares in Q1 2026, an estimated $17.4K.
- Veracyte made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1605 holding.
- AllianceBernstein first reported a position in Veracyte in Q2 2014 and has held it in 36 quarters since.
- AllianceBernstein's Veracyte position peaked at $4.66M in Q4 2021.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.